Does anti-nerve growth factor monoclonal antibody treatment have the potential to replace nonsteroidal anti-inflammatory drugs and opioids in treating hip or knee osteoarthritis? A systematic review of randomized controlled trials.

Zhao, Di; Zeng, Ling-Feng; Liang, Gui-Hong; Pan, Jian-Ke; Luo, Ming-Hui; Han, Yan-Hong; Liu, Jun; Yang, Wei-Yi

Zhao, Di; Zeng, Ling-Feng; Liang, Gui-Hong; Pan, Jian-Ke; Luo, Ming-Hui; Han, Yan-Hong; Liu, Jun; Yang, Wei-Yi.

Afiliação

Zhao D; The Second Clinical School of Guangzhou University of Chinese Medicine, Guangzhou, China.
Zeng LF; Bone and Joint Research Team of Degeneration and Injury, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, China.
Liang GH; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Pan JK; Bone and Joint Research Team of Degeneration and Injury, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, China.
Luo MH; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Han YH; Bone and Joint Research Team of Degeneration and Injury, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, China.
Liu J; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Yang WY; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.

EFORT Open Rev ; 7(7): 470-480, 2022 Jul 05.

Article em En | MEDLINE | ID: mdl-35900204

Palavras-chave

OA; anti-NGF monoclonal antibody; osteoarthritis; randomized controlled trials; systematic review

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Idioma: En Revista: EFORT Open Rev Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google